Diagnosis of glioma recurrence using multiparametric dynamic 18F-fluoroethyl-tyrosine PET-MRI

Thomas Pyka, Daniela Hiob, Christine Preibisch, Jens Gempt, Benedikt Wiestler, Jürgen Schlegel, Christoph Straube, Claus Zimmer

Publikation: Beitrag in FachzeitschriftArtikelBegutachtung

92 Zitate (Scopus)

Abstract

Objectives: To investigate the value of combined 18F-fluorethyltyrosine-(FET)-PET/MRI for differentiation between recurrence and treatment-related changes in glioma patients. Methods: 63 lesions suggestive of recurrence in 47 glioma patients were retrospectively identified. All patients had a dynamic FET scan, as well as morphologic MRI, PWI and DWI on a hybrid PET/MRI scanner. Lesions suggestive of recurrence were marked. ROC analysis was performed univariately and on parameter combination. Results: 50 lesions were classified as recurrence, 13 as radiation necrosis. Diagnosis was based on histology in 23 and follow-up imaging in 40 cases. Sensitivities and specificities for static PET were 80 and 85%, 66% and 77% for PWI, 62 and 77% for DWI and 64 and 79% for PET time-to-peak. AUC was 0.86 (p < 0.001) for static PET, 0.73 (p = 0.013) for PWI, 0.70 (p = 0.030) for DWI and 0.73 (p < 0.001) for dynamic PET. Multiparametric analysis resulted in an AUC of 0.89, notably yielding sensitivity of 76% vs. 56% for PET alone at 100% specificity. Conclusion: Simultaneous dynamic FET-PET/MRI was reliably feasible for imaging of recurrent glioma. While all modalities were able to discriminate between recurrence and treatment-related changes, multiparametric analysis added value especially when high specificity was demanded.

OriginalspracheEnglisch
Seiten (von - bis)32-37
Seitenumfang6
FachzeitschriftEuropean Journal of Radiology
Jahrgang103
DOIs
PublikationsstatusVeröffentlicht - Juni 2018

Fingerprint

Untersuchen Sie die Forschungsthemen von „Diagnosis of glioma recurrence using multiparametric dynamic 18F-fluoroethyl-tyrosine PET-MRI“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren